A customizable protein, Crunch, harnesses the body’s natural cleanup system to remove harmful cells, opening new potential ...

Electrical stimulation of macrophages could represent a new therapy to boost the body’s own repair processes in a range of ...

Novartis has agreed to license and develop Arrowhead Pharmaceuticals’ preclinical stage small interfering RNA (siRNA) therapy ...

Codomax is developing and planning to license out cell lines adapted to cope with the stresses of customers’ manufacturing processes.

A small-scale model validating viral clearance addresses the specific challenges of continuous manufacturing bioprocesses.

Generic to-do list will aid drug manufacturers during technology transfer from pilot to commercial-scale production, say NIIMBL developers.

The In Vivo Imaging Center of Excellence in North Carolina was designed to allow Revvity to drive innovation at a faster pace.

A novel decoy mechanism targets the once therapeutically elusive STAT3 transcription factor and mitigates cat oral cancer in a clinical trial.

In the rapidly evolving field of lipid nanoparticle (LNP) research, the integration of advanced technologies is crucial for ...

Findings suggest that because the brain maps are preserved, it may, theoretically, be possible to restore movement to a ...

Single-cell proteomics with RNA sequencing uncover hidden gene expression dynamics in stem cell differentiation.

Blueprint for ovarian reserve cell development identifies critical development milestones, risk factors for hormone-related disorders.